Healthy Body, Healthy Bones After Bariatric Surgery Trial
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
One in three adults in the United States suffers from obesity. Bariatric surgery is an
increasingly utilized and effective treatment for obesity and obesity-related comorbidities,
however, the massive weight loss associated with bariatric surgery adversely affects bone
leads to an increased risk of fracture. Bisphosphonate medications, such as zoledronic acid,
are used to treat bone loss in patients with osteoporosis, and this study investigates
whether this medication can prevent bone loss associated with surgical weight loss
procedures.